No­var­tis hands off $80M in cash to part­ner up with a top biotech play­er in the fi­bro­sis sec­tor

Nev­er un­der­es­ti­mate the pow­er of a good show­ing at a sci­en­tif­ic con­fer­ence.
In a pre­sen­ta­tion late last year, the re­searchers at Pli­ant Ther­a­peu­tics …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER